Reorganizing the respiratory high dependency unit for pandemics

Abstract

Introduction : Respiratory high dependency units (RHDU) set up in European countries in the last decade are based on being a transitional step between the intensive care units (ICU) and the conventional hospital ward in terms of staffing, level of monitoring and patients’ severity. In the pre-COVID-19 era, its main use has been the treatment of hypercapnic acute-on-chronic respiratory failure with noninvasive respiratory support and more recently for hypoxemic acute respiratory failure Areas Covered We searched the following databases: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, limited to the terms: COVID-19 AND RHDU, Respiratory Intermediate care Unit, acute respiratory distress syndrome (ARDS), non invasive ventilation (NIV), high flow nasal cannula (HFNC), prone position, monitoring. In this review we summarize RHDU´s dual purpose: on one hand, to decrease the number of admissions into ICU, and on the other hand, early discharges of patients from ICU with prolonged admissions due to the need of care or laborious weaning from invasive mechanical ventilation. Although this dual purpose of RHDUs has contributed to decrease the overload of the ICUs during the pandemic, the hundreds of patients admitted in hospitals, with approximately 20% -30% needing critical care, has exceeded the forecasts of many hospitals. Expert opinion It seems clear that a reorganization and optimization of the care of patients with severe COVID-19 is necessary, minimizing admissions to the ICU and facilitating an early discharge. During the pandemic, several hospitals have spontaneously created new RHDUs or extended pre-existing RHDUs or up-graded respiratory wards in order to receive less sick patients requiring lower levels of monitoring and nurse to patient ratios. This article reviews under a European expert perspective this topic and proposes an adaptation and optimization of the RHDUs to meet the emergent needs caused by the pandemic emphasizing the role of the expert application of noninvasive respiratory therapies in preventing intubation and ICU access.